Evidence map›Paper›PMID 34221391›Full record

ArticleClinical kidney journal2021

Founding mutations explains hotspots of polycystic kidney disease in Southern Spain.

Carmen García Rabaneda, Francisco Perea, María Luz Bellido Díaz, Ana I Morales García, Margarita Martínez Atienza, Lisbeth Sousa Silva, Miguel Ángel García González, Francisco Ruiz-Cabello, Rafael J Esteban de la Rosa

Erratum issuedOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Carmen García RabanedaServicio de Análisis Clínicos, Hospital Universitario San Cecilio, Granada, Spain.ORCID https://orcid.org/0000-0001-9290-1196
Francisco PereaServicio de Análisis Clínicos e Inmunología, UGC Laboratorio Clínico, Granada, Spain.
María Luz Bellido DíazGrupo de Estudio de la Enfermedad Poliquística Autosómica Dominante (GEEPAD), Granada, Spain.
Ana I Morales GarcíaGrupo de Estudio de la Enfermedad Poliquística Autosómica Dominante (GEEPAD), Granada, Spain.
Margarita Martínez AtienzaGrupo de Estudio de la Enfermedad Poliquística Autosómica Dominante (GEEPAD), Granada, Spain.
Lisbeth Sousa SilvaLaboratorio de Genética del Complejo Hospitalario Universitario de Santiago de Compostela (NEFROCHUS) Spain.
Miguel Ángel García GonzálezLaboratorio de Genética del Complejo Hospitalario Universitario de Santiago de Compostela (NEFROCHUS) Spain.
Francisco Ruiz-CabelloServicio de Análisis Clínicos e Inmunología, UGC Laboratorio Clínico, Granada, Spain.
Rafael J Esteban de la RosaGrupo de Estudio de la Enfermedad Poliquística Autosómica Dominante (GEEPAD), Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESComplejo Hospitalario Universitario de Santiago · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our group identified two pathogenic variants on the

Indexed as

ADPKDcommon ancestordisease-associated haplotypefounding mutationhotspotsSouthern Spain

Identifiers

PMID34221391
PMCPMC8243269
OpenAlexW3111199987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.